[PDF][PDF] Inflammatory Markers or Composite Index in COVID-19 as ̳Point Of Care Test ': Which One is the Best Choice to Tackle Dragon

S Patil, G Gondhali - South Asian Res J Med Sci, 2023 - researchgate.net
COVID-19 is first corona virus related global pandemic after SARS and MERS and due to
rapid evolution of pandemic fast track developments in diagnostics, monitoring and …

[HTML][HTML] Clinical and laboratory predictors of mortality in COVID-19 infection: a retrospective observational study in a tertiary care hospital of Eastern India

D Rai, A Ranjan, H Ameet, S Pandey - Cureus, 2021 - ncbi.nlm.nih.gov
Objective To assess clinical & laboratory parameters associated with adverse outcomes
among 984 patients with COVID-19 infection admitted to a tertiary care hospital in eastern …

[HTML][HTML] Inflammatory markers and COVID-19 disease progression

SK Sidhwani, T Mirza, A Khatoon, F Shaikh… - Journal of Infection and …, 2023 - Elsevier
Background The COVID-19 pandemic has resulted in a global humanitarian crisis. Despite
ongoing research, transmission risks and many disease characteristics remained unclear …

The role of C-reactive protein as a prognostic marker in COVID-19

D Stringer, P Braude, PK Myint, L Evans… - International journal …, 2021 - academic.oup.com
Background C-reactive protein (CRP) is a non-specific acute phase reactant elevated in
infection or inflammation. Higher levels indicate more severe infection and have been used …

[HTML][HTML] Inflammatory biomarkers as independent prognosticators of 28-day mortality for COVID-19 patients admitted to general medicine or ICU wards: a retrospective …

T Pitre, A Jones, J Su, W Helmeczi, G Xu, C Lee… - Internal and emergency …, 2021 - Springer
Inflammatory biomarkers may be associated with disease severity and increased mortality in
COVID-19 patients but have not been studied in North American populations. We sought to …

Cytokines and their relationship with the severity and prognosis of coronavirus disease 2019 (COVID-19): a retrospective cohort study

QQ Liu, A Cheng, Y Wang, H Li, L Hu, X Zhao… - BMJ open, 2020 - bmjopen.bmj.com
Objective To delineate the characteristics and clinical significance of plasma inflammatory
cytokines altered in COVID-19. Design Retrospective, single-centre cohort study. Setting …

Multi-inflammatory index as a novel mortality predictor in critically ill COVID-19 patients

HT Gozdas, SA Kayis, T Damarsoy… - Journal of Intensive …, 2022 - journals.sagepub.com
Aim Systemic inflammation has a crucial role in the pathogenesis and mortality of
Coronavirus disease 2019 (COVID-19). Multi-inflammatory index (MII) is a novel index …

[HTML][HTML] Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta …

BM Henry, MHS De Oliveira, S Benoit… - Clinical Chemistry and …, 2020 - degruyter.com
Background As coronavirus disease 2019 (COVID-19) pandemic rages on, there is urgent
need for identification of clinical and laboratory predictors for progression towards severe …

Impacts of demographic and clinical characteristics on disease severity and mortality in patients with confirmed COVID-19

A Az, O Sogut, T Akdemir, H Ergenc… - … Journal of General …, 2021 - Taylor & Francis
Background We investigated potential predictive factors for mortality and disease severity
from demographic and clinical data, comorbidities, and laboratory findings in patients with …

[HTML][HTML] Inflammatory mediators profile in patients hospitalized with COVID-19: A comparative study

A Tufa, TH Gebremariam, T Manyazewal… - Frontiers in …, 2022 - frontiersin.org
Abnormal inflammatory mediator concentrations during SARS-CoV-2 infection may
represent disease severity. We aimed to assess plasma inflammatory mediator …